Unicycive Therapeutics financial statements provide useful quarterly and yearly information to potential Unicycive Therapeutics investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Unicycive Therapeutics financial statements helps investors assess Unicycive Therapeutics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Unicycive Therapeutics' valuation are summarized below:
Market Capitalization
61.5 M
Enterprise Value Revenue
16.632
Earnings Share
(0.46)
We have found one hundred twenty available fundamental trend indicators for Unicycive Therapeutics, which can be analyzed and compared to other ratios and to its competition. All investors should make sure to double-check all of Unicycive Therapeutics current market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road. Market Cap is likely to drop to about 22.1 M in 2025. Enterprise Value is likely to drop to about 12.8 M in 2025
Unicycive Therapeutics investors use historical fundamental indicators, such as Unicycive Therapeutics' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Unicycive Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When running Unicycive Therapeutics' price analysis, check to measure Unicycive Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Unicycive Therapeutics is operating at the current time. Most of Unicycive Therapeutics' value examination focuses on studying past and present price action to predict the probability of Unicycive Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Unicycive Therapeutics' price. Additionally, you may evaluate how the addition of Unicycive Therapeutics to your portfolios can decrease your overall portfolio volatility.